Mon, June 14, 2021
Sun, June 13, 2021
Fri, June 11, 2021
Thu, June 10, 2021

Mohit Bansal Maintained (VRTX) at Strong Buy with Decreased Target to $285 on, Jun 11th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-285-on-jun-11th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Mohit Bansal of Citigroup, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Decreased Target from $325 to $285 on, Jun 11th, 2021.

Mohit has made no other calls on VRTX in the last 4 months.



There are 2 other peers that have a rating on VRTX. Out of the 2 peers that are also analyzing VRTX, 0 agree with Mohit's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Mohit


  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $279 on, Wednesday, May 12th, 2021
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy and Held Target at $260 on, Monday, May 3rd, 2021